Due to the government shutdown, updates to information on this website may be limited or delayed. State Medicaid and Children’s Health Insurance Programs (CHIP) continue to operate. Continue to work with the programs in your state to access coverage. For more information about government operating status, visit OPM.gov.

U.S. flag

An official website of the United States government

Federal Disaster Resources

This page provides federal resources that are helpful during emergencies and disasters. We also created Medicaid & CHIP disaster preparedness toolkits to provide states and territories with additional disaster-related information.

Section 1135 Waiver Flexibilities - Ohio Coronavirus Disease 2019 (Fourth Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Ohio for multiple section 1135 flexibilities on April 22, 2020. Your follow-up communication to CMS on January 12, 2021 indicated Ohio’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - Maryland Coronavirus Disease 2019 (Sixth Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Maryland for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Maryland’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - Delaware Coronavirus Disease 2019 (Third Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Delaware for multiple section 1135 flexibilities on March 27, 2020.  Your follow-up communication to CMS on January 13, 2021 indicated Delaware’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - Alabama Coronavirus Disease 2019 (Third Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Alabama for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Alabama’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - Massachusetts Coronavirus Disease 2019 (Sixth Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Massachusetts for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Massachusetts’ response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - Montana Coronavirus Disease 2019 (Fourth Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Montana for multiple section 1135 flexibilities on March 30, 2020. Your follow-up communication to CMS on January 14, 2021, indicated Montana’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - Connecticut Coronavirus Disease 2019 (Fourth Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Connecticut for multiple section 1135 flexibilities on March 27, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Connecticut’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - New Mexico Coronavirus Disease 2019 (Third Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of New Mexico for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communication to CMS on January 14, 2021 indicated New Mexico’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - New Hampshire Coronavirus Disease 2019 (Fourth Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of New Hampshire for multiple section 1135 flexibilities on March 23, 2020 Your follow-up communication to CMS on January 12, 2021 indicated New Hampshire’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

Section 1135 Waiver Flexibilities - North Carolina Coronavirus Disease 2019 (Fifth Request)

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of North Carolina for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communication to CMS on January 14, 2021 indicated North Carolina’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
Show entries